Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Net Cash Flow: 2020-2025

Historic Net Cash Flow for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Sep 2025 value amounting to -$26.3 million.

  • Maravai Lifesciences Holdings' Net Cash Flow fell 627.98% to -$26.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$334.5 million, marking a year-over-year decrease of 23003.38%. This contributed to the annual value of -$252.6 million for FY2024, which is 341.73% down from last year.
  • Latest data reveals that Maravai Lifesciences Holdings reported Net Cash Flow of -$26.3 million as of Q3 2025, which was down 75.09% from -$15.0 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Net Cash Flow ranged from a high of $172.9 million in Q3 2021 and a low of -$255.8 million during Q4 2024.
  • Its 3-year average for Net Cash Flow is -$35.3 million, with a median of -$13.3 million in 2024.
  • Its Net Cash Flow has fluctuated over the past 5 years, first spiked by 1,552.97% in 2021, then plummeted by 5,408.46% in 2024.
  • Maravai Lifesciences Holdings' Net Cash Flow (Quarterly) stood at $3.5 million in 2021, then surged by 318.93% to $14.7 million in 2022, then tumbled by 131.60% to -$4.6 million in 2023, then slumped by 5,408.46% to -$255.8 million in 2024, then slumped by 627.98% to -$26.3 million in 2025.
  • Its Net Cash Flow stands at -$26.3 million for Q3 2025, versus -$15.0 million for Q2 2025 and -$37.4 million for Q1 2025.